Compound 2133
Identifiers
- Canonical SMILES:
Cn1ccc2cc[nH]c(=O)c12
- IUPAC name:
1-methyl-1H,6H,7H-pyrrolo[2,3-c]pyridin-7-one
- InChi:
InChI=1S/C8H8N2O/c1-10-5-3-6-2-4-9-8(11)7(6)10/h2-5H,1H3,(H,9,11)
- InChiKey:
MKLDTQZQFAGIBR-UHFFFAOYSA-N
External links
![]() 52908295 |
![]() CHEMBL2436001 |
External search
|
|
|
|
|
Bibliography (1)
Pharmacological data
| Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
|---|---|---|---|
| 0 | 0 | 0 | 0 |
Targets
| PPI family | Best activity | Diseases | MMoA |
|---|
Physicochemical filters
| Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
|---|---|---|---|---|
| Compliance | ||||
| MW | 148.06 g/mol | |||
| HBA | 3 | |||
| HBD | 1 | |||
| HBA + HBD | 4 | |||
| AlogP | 0.55 | |||
| TPSA | 34.03 | |||
| RB | 0 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
| Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 |
Pharmacological data
| Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
|---|
| Ta | Structure | Name | Drugbank ID |
|---|---|---|---|
| 0.6379 | 1-Methyl-2-quinolone | DB04580 | |
| 0.5417 | 9-Deazahypoxanthine | DB04095 | |
| 0.5172 | 2-Hydroxyquinoline | DB04745 | |
| 0.5000 | 9-Deazaguanine | DB04356 | |
| 0.5000 | Pirfenidone | DB04951 | |
| 0.4744 | 3,4-Dihydroxy-1-Methylquinolin-2(1h)-One | DB01754 | |
| 0.4667 | Euflavine | DB13326 | |
| 0.4535 | Hydronidone | DB06299 | |
| 0.4430 | 3,5,6,8-Tetramethyl-N-Methyl Phenanthrolinium | DB02310 | |
| 0.4412 | Methaqualone | DB04833 | |
| 0.4390 | FG-9041 | DB03759 | |
| 0.4386 | 1,10-Phenanthroline | DB02365 | |
| 0.4255 | 5-ETHYL-3-METHYL-1,5-DIHYDRO-4H-PYRAZOLO[4,3-C]QUINOLIN-4-ONE | DB07158 | |
| 0.4189 | Cridanimod | DB13674 | |
| 0.4130 | Imiquimod | DB00724 |




